Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx ProductsAccesswire • 01/25/23
Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical SpasAccesswire • 01/04/23
Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United StatesAccesswire • 10/27/22
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, GermanyAccesswire • 10/06/22
Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical SupplyAccesswire • 08/02/22
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial ResultsAccesswire • 07/13/22
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19Business Wire • 06/01/22
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.Business Wire • 05/03/22
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?InvestorPlace • 03/30/22
Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South AfricaBenzinga • 03/30/22
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South AfricaBusiness Wire • 03/30/22
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022Business Wire • 01/05/22
Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast AsiaBusiness Wire • 11/09/21
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill TimeBusiness Wire • 10/15/21